|Alchemia Limited -- Australia Stock|| |
AUD 0.012 0.002 20.00%
Group Financial Controller
Mr. Imran Ahamed is Group Financial Controller of Alchemia Ltd. He was appointed to the position of Group Financial Controller in February 2013, following one year as Alchemia Oncologys Financial Controller. He brings over 20 years of accounting and finance experience to the role, having worked in senior finance positions in investment banking, manufacturing, retail and wholesale sectors in Asia, Southern Africa, the Middle East and Australia. Imrans expertise includes strong technical skills in financial and management accounting, statutory reporting, budgeting and control, systems and procedures and financial analysis. He has also been involved in corporate finance transactions which include IPOs, MAs, capital restructuring and feasibility studies.
Executive Since 2013
61 3 9692 7222 http://www.alchemia.com.au
The company has return on total asset (ROA)
of (12.2) %
which means that it has lost $12.2 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE)
of (19.59) %
meaning that it generated substantial loss on money invested by shareholders.
The company seeks out business development opportunities in the life sciences and other sectors. Alchemia Limited was founded in 1995 and is headquartered in South Melbourne, Australia. Alchemia Limited operates under Biotechnology classification in Australia and traded on Australian Securities Exchange exchange.Alchemia Limited (ACL) is traded on Australian Securities Exchange in Australia. It is located in 100 Albert Road and employs 29 people.